Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for funding

EFPIA Disclosure Code

Grünenthal’s commitment

Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and supports the new EFPIA Disclosure (Transparency) code of conduct. As a member of EFPIA we are fully committed to publish our collaboration with healthcare professionals (HCPs) and healthcare organizations (HCOs) to demonstrate that we interact with HCPs and HCOs in an ethical and transparent way.

EFPIA - Introducing the Disclosure Code

All transfers of value to HCPs and HCOs have been collected since 2015 being reported the year after it occurs. This includes,

Grants and donations to HCOs
Speaker and consultancy fees for HCPs
Sponsoring of events organized by or on behalf of HCOs
Invitation of HCPs to congresses and educational or scientific Meetings
Research and development related transfers of value (only as aggregated Report)

Please visit the EFPIA website: https://efpia.eu/relationships-code/healthcare-professionals-hcps/ to receive further information about the new EFPIA Transparency Code

The proposed EFPIA format for the disclosure report is used by the local pharma associations in Europe which are direct members of EFPIA. The report defines the different categories and how to disclose transfer of values to HCPs and HCOs on an annual basis.

Working together for patients

EFPIA Disclosure Code

Grünenthal’s commitment

Explore more